Deal Announcements

Advaxis Raises $5 Million In Venture Capital Funding

Tuesday, September 29, 2009 5:30:00 AM PDT | VentureDeal Staff

North Brunswick, New Jersey  --  Biotechnology company Advaxis has secured $5 million in a new round of venture capital financing.

Advaxis says that it is using a bio-engineered bacterium to "activate the immune system to treat cancer, infectious disease or allergic syndromes."

Investors in around when not disclose, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1